PD+H: What does a new drug commercialisation pathway entail?

This event was held on Friday 26 May 2023

Share this event

We are delighted to welcome Dr David Fuller, internationally experienced biopharmaceutical executive, to provide essential insights on what a new drug commercialisation pathway actually entails. This webinar will cover:

  • Defining a commercial product versus an idea
  • Starting with the end in mind
  • IP considerations
  • Clinical indication(s)
  • Regulatory aspects
  • Defining your target market
  • Key value-adding steps

Who should attend

  • PhD students
  • Postdoctoral researchers
  • Early and mid-career researchers
  • Industry-engaged academics
  • Industry-engaged professional staff

What you'll experience

PD+ is a free weekly webinar series that takes place every Friday from 12-1PM. It is the perfect way to lunch and level up your industry engagement and commercialisation skills.

Meet your Presenter: Dr David Fuller

Dr David Fuller is currently Chief Medical Officer, Race Oncology and Chairman of EpiAxis Therapeutics, a privately owned epigenetic therapeutic and diagnostic company, and is a Non-Executive Director of the ASX- listed biotech company, AdAlta (ASX: 1AD). He has more than 30 years of R&D experience, spanning large, mid and small cap companies including pre-clinical and clinical development, medical and regulatory affairs, and commercialisation. Most recently Dr Fuller was the Senior Vice President of Clinical Development in the Oncology Business Unit at Syneos Health Clinical Solutions. Prior to this he was a Director at Linear Clinical Research, Chairman of Dimerix Bioscience, CMO/COO at Trident Clinical Research, CMO at Arana Therapeutics, and Vice-President Clinical at Genzyme Europe.

Register

Event is free but registration is essential

PD+ streams: MedTech and Life Sciences | Commercialisation of Research

The PD+ webinar series is brought to you by the University of Newcastle's Knowledge Exchange and Enterprise (KEE) and Campus Plus.  Find out about upcoming PD+ webinars and catch up on recordings of previous PD+ webinars at the Research Advantage Knowledge Hub.

=================

What is KEE?

The University of Newcastle's Knowledge Exchange and Enterprise (KEE) is responsible for facilitating impact within our regions through intellectual property commercialisation, business development, and entrepreneurship. KEE works with researchers and industry to identify and facilitate high-value licenses and research collaborations, in addition to supporting pre-startups, startups, and scale-up companies.

=================

Event Information

  • Date:  This event was held on Friday 26 May 2023
  • Location: via Zoom